These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Identification of human CML target. HLA-B locus (B12) antigen variants defined by CTL generated between B locus-identical (B12) responder-stimulator pairs. Kato S, Iványi P, Lacko E, Breur B, Du Bois R, Eijsvoogel VP. J Immunol; 1982 Feb; 128(2):949-55. PubMed ID: 6976390 [Abstract] [Full Text] [Related]
13. Cell-mediated lymphocytotoxicity directed against HLA-D gene products. Albrechtsen D, Arnesen E, Thorsby E. Transplantation; 1979 May; 27(5):338-41. PubMed ID: 432943 [Abstract] [Full Text] [Related]
14. Antigenicity of HLA-D locus antigens in human cell-mediated lympholysis. Ohsawa N, Akiyama N. Jpn J Exp Med; 1983 Feb; 53(1):65-8. PubMed ID: 6308312 [No Abstract] [Full Text] [Related]
15. Intra HLA-D/DR region recombinant detected by primed lymphocyte typing (PLT). Jakobsen BK, Kristensen T, Lamm LU, Morling N, Bruun-Petersen G, Platz P, Ryder LP, Svejgaard A. Tissue Antigens; 1983 Aug; 22(2):123-33. PubMed ID: 6578608 [Abstract] [Full Text] [Related]
16. Expression of HLA antigens on renal tubular cells in culture. II. Effect of increased HLA antigen expression on tubular cell stimulation of lymphocyte activation and on their vulnerability to cell-mediated lysis. Bishop GA, Waugh JA, Hall BM. Transplantation; 1988 Aug; 46(2):303-10. PubMed ID: 2970135 [Abstract] [Full Text] [Related]
17. Secondary MLC responses of primed lymphocytes after selective sensitization to non-HLA-D determinants. Wank R, Schendel DJ, Blanco ME, Dupont B. Scand J Immunol; 1979 Aug; 9(6):499-505. PubMed ID: 88755 [Abstract] [Full Text] [Related]